Metabolic factors associated with benign prostatic hyperplasia - Wikidata - awgldk - TriplyDB

Metabolic factors associated with benign prostatic hyperplasia

Metabolic factors associated with benign prostatic hyperplasia

http://www.wikidata.org/entity/Q37104427

about

The impact of obesity towards prostate diseases Hyperglycemia and insulin resistance and the risk of BPH/LUTS: an update of recent literature Serum adiponectin, C-peptide and leptin and risk of symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial.Finasteride reduces the risk of incident clinical benign prostatic hyperplasia Ventral prostate fibrosis in the Akita mouse is associated with macrophage and fibrocyte infiltration.Progression of lower urinary tract symptoms in older men: a community based study.Surgical intervention for symptomatic benign prostatic hyperplasia is correlated with expression of the AP-1 transcription factor network Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk Factors.Benign prostatic hyperplasia: from bench to clinic Risk of cancer in a large cohort of U.S. veterans with diabetes.5α-reductase type 1 modulates insulin sensitivity in men.Pioglitazone attenuates prostatic enlargement in diet-induced insulin-resistant rats by altering lipid distribution and hyperinsulinaemia.Benign prostatic hyperplasia is a significant risk factor for bladder cancer in diabetic patients: a population-based cohort study using the National Health Insurance in Taiwan.Impact of type 2 diabetes on lower urinary tract symptoms in men: a cohort study.Community-based research on the benign prostatic hyperplasia prevalence rate in Korean rural area.Relationship between metabolic syndrome and prostate volume in Korean men under 50 years of age.Linking pre-diabetes with benign prostate hyperplasia. IGFBP-3: a conductor of benign prostate hyperplasia development orchestra?Associations between modest weight changes and onset and progression of lower urinary tract symptoms in two population-based cohorts.Metabolic syndrome and benign prostatic hyperplasia: evidence of a potential relationship, hypothesized etiology, and prevention.Prostate size correlates with fasting blood glucose in non-diabetic benign prostatic hyperplasia patients with normal testosterone levels.PPARγ: a molecular link between systemic metabolic disease and benign prostate hyperplasia.Lower urinary tract symptoms in men.Can metabolic disorders in aging men contribute to prostatic hyperplasia eligible for transurethral resection of the prostate (TURP)?Waist circumference and risk of lower urinary tract symptoms: a meta-analysis.Prevalence and trends of urinary incontinence in adults in the United States, 2001 to 2008 Towards the prevention and management of prostatic diseases in Nigeria: a framework.Association of metabolic syndrome and benign prostate enlargement in young korean males.Obesity increases and physical activity decreases lower urinary tract symptom risk in older men: the Osteoporotic Fractures in Men study.Genetic Determinants of Metabolism and Benign Prostate Enlargement: Associations with Prostate Volume.Relationship between Metabolic Syndrome and Lower Urinary Tract Symptoms: Hallym Aging Study.Benign prostatic hyperplasia complicated with T1DM can be alleviated by treadmill exercise-evidences revealed by the rat model Does Inflammation Mediate the Obesity and BPH Relationship? An Epidemiologic Analysis of Body Composition and Inflammatory Markers in Blood, Urine, and Prostate Tissue, and the Relationship with Prostate Enlargement and Lower Urinary Tract Symptoms.Association between benign prostatic hyperplasia, body mass index, and metabolic syndrome in Chinese men.PPARγ isoforms differentially regulate metabolic networks to mediate mouse prostatic epithelial differentiation.Association between physical activity, lower urinary tract symptoms (LUTS) and prostate volume.Benign prostatic enlargement can be influenced by metabolic profile: results of a multicenter prospective study.Association between biomarkers of obesity and risk of high-grade prostatic intraepithelial neoplasia and prostate cancer--evidence of effect modification by prostate size Age and Obesity Promote Methylation and Suppression of 5α-Reductase 2: Implications for Personalized Therapy of Benign Prostatic Hyperplasia.NF-κB and androgen receptor variant expression correlate with human BPH progression Challenging the Inevitability of Prostate Enlargement: Low Levels of Benign Prostatic Hyperplasia Among Tsimane Forager-Horticulturalists

P2860

Q26750847-41A90C40-790C-4E09-91C9-11E1712EC4D4 Q27011347-3678F86B-BBCF-4D70-B113-3DC0E58175B5 Q33725858-D03DDC42-3B3D-4A33-85BE-544687FC7C42 Q33762340-A440560C-7DD2-4303-A4D4-F895B6A0737F Q33820772-EF5BD98F-0FE2-4CFB-8ADC-E98501AF187B Q33958191-B42F4636-3CE4-48DA-A60A-3B48AB637688 Q34163024-628534DD-2E88-4203-8001-B3CCC17EC7EE Q34176834-47C3E8B4-333A-407F-B7DF-FA0F7297AFB2 Q34216723-DE37368A-1689-43F9-BCDA-622FE8DC1629 Q34234264-84F43964-86A4-43B7-B0BE-B40985A1EFE9 Q34396472-45BAB992-A6A7-48B3-BAD7-1AA9FF16FC9C Q34442391-127456DC-309B-4924-A1B2-A711186B407C Q34535741-C4182009-D4AC-4230-9768-2E051BFE13E8 Q34591489-AB0DC5A8-B312-4936-8FFC-CA1BF2803723 Q34962509-A84992F8-7365-43AF-8BF6-AADE141F6A09 Q35070014-92E58280-CFDF-4685-B54B-E4C3EDB54894 Q35075205-993F4A67-381D-4469-8351-5F0B98AEF844 Q35154271-D2C616D1-CBBC-494F-83CA-D086AE3DAF42 Q35182377-CF2731CB-C57D-4663-AF74-07823E375F07 Q35214163-01C25CE2-E6F4-4FEC-88AA-E2B6497D5182 Q35216293-AF93A97D-CD2D-4036-87A3-82E7DC8F0D06 Q35225398-55EA4E7F-1E2D-41D2-94DB-8A90F55A0AA5 Q35228167-CAFEBB4F-C3CC-423E-A1B5-12E65F1294EE Q35312593-5906D26E-2338-47BA-8D49-2D7B5FE13671 Q35394236-E2952E16-151A-41C4-88D4-3C92164F99A5 Q35550448-FC93CD6D-9511-477A-B1B5-98B8A24130EC Q35624518-58C1C43D-7113-4EDB-9933-E1A41FF64D91 Q35632649-FCEC40D1-6297-4B98-AB66-338A959139E9 Q35687087-37855339-C330-4F46-AD7C-040A2D295E0A Q35823776-E8498CF1-A8A4-404F-9ACA-075F27E72571 Q35843929-5FC77844-EE1B-48CE-836B-69DB75DC92D2 Q36059979-EA505587-1B69-400F-A398-9CBBE4008FC7 Q36080363-27C9426C-4CB1-4A7A-9ADA-C953BA9E2169 Q36211459-D3E32DDE-2C00-47CD-BFC9-62FD5DB6CF0C Q36284900-42101C3B-845A-4852-B307-39968019E24F Q36334566-3EB1E35D-D88B-4CA7-8D84-C656CCACE085 Q36442301-54EF1FCE-DFA3-48C8-9A08-57C74AE3104C Q36602183-9FE46DC4-4DE8-4304-9D4E-9689E7E5D8ED Q36606285-1DAE2DCC-E49C-4C19-A91D-02C6CCF7F407 Q36853498-3D42B9C5-6F33-4B9C-A182-BBE2B6DF8EC9

P2860

Metabolic factors associated with benign prostatic hyperplasia

http://www.wikidata.org/entity/Q37104427

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 April 2006

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Metabolic factors associated with benign prostatic hyperplasia

@en

Metabolic factors associated with benign prostatic hyperplasia.

@nl

type

label

Metabolic factors associated with benign prostatic hyperplasia

@en

Metabolic factors associated with benign prostatic hyperplasia.

@nl

prefLabel

Metabolic factors associated with benign prostatic hyperplasia

@en

Metabolic factors associated with benign prostatic hyperplasia.

@nl

P1433

Q37104427-C07B8F9D-AA77-44E1-BCAF-50BB0F884A60

P1476

Q37104427-27FFAB0F-5D5E-47D4-942C-A9A6BAB8205F

P2093

Q37104427-0A72075D-1B24-4E74-BF19-5149701CFC12

Q37104427-42832E13-A47E-49C0-BD53-C95B80190DB8

Q37104427-47F50579-AEBC-4DAB-B64A-F7F2DB9D3725

Q37104427-63873934-7865-42DC-8A7E-17831DCE1341

Q37104427-644F2CAA-1D9C-40B5-A14D-D2BEF6C9E552

Q37104427-685A804B-99D3-4BD2-9651-49D0142F6818

Q37104427-E8F58436-94FB-438A-9BDC-3421CDD440C3

P2860

Q37104427-01796C41-F1A7-45BF-B7D0-B6670E13BB7D

Q37104427-02B70AB6-CA78-4438-AB6D-F9FDF9C7EE27

Q37104427-08F4BDCE-9B17-4803-B01E-CD8E08127ADF

Q37104427-08F9644D-53F8-4FE0-B0C9-A43219F0013C

Q37104427-13982029-2933-4C91-A7EF-1EB0735A511E

Q37104427-1E6035CD-6A90-4193-AF92-6AE7DABE6FD8

Q37104427-22D9772D-B0EC-47C1-88CE-30991A92943C

Q37104427-25F6FC4D-40A3-4B29-903B-071D302F5DA6

Q37104427-2C8BC475-35F1-4647-85EA-7304A7A1A01C

Q37104427-31F73A26-E9AF-411D-BDBF-1C6B896F89BB

P304

Q37104427-94F03851-8534-4E7F-AAD4-027AEE5C815D

P31

Q37104427-141EC901-B3EF-4EF6-824E-09624D100660

P356

Q37104427-66ECDBD0-B50A-43E5-8B72-FADB68C37C77

P407

Q37104427-B9AA303E-EEC3-48A7-9F03-93CDC49982EE

P433

Q37104427-48F5BF16-5357-4DF3-9F55-5EAC153EE50C

P478

Q37104427-D3A1EE4F-E21D-442D-8B0E-139F51873C34

P50

Q37104427-67413450-EF92-45CE-8C4F-B214B2CC9B22

P577

Q37104427-F0DBC92B-A871-45A7-B44D-429CB2148D5F

P5875

Q37104427-936E174A-FBAE-4CF0-BC37-C64B25EC02DF

P698

Q37104427-946DE939-5E1E-4C1C-A728-39F0EA5063BF

P932

Q37104427-9314D00A-BC5F-4C2C-BB4C-3BBD19F7EE4D

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Metabolic factors associated with benign prostatic hyperplasia

@en

P2093

B Gwen Windham

http://www.w3.org/2001/XMLSchema#string

E Jeffrey Metter

http://www.w3.org/2001/XMLSchema#string

Elizabeth A Platz

http://www.w3.org/2001/XMLSchema#string

H Ballentine Carter

http://www.w3.org/2001/XMLSchema#string

J Kellogg Parsons

http://www.w3.org/2001/XMLSchema#string

Luigi Ferrucci

http://www.w3.org/2001/XMLSchema#string

Patricia Landis

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence and Trends in Obesity Among US Adults, 1999-2000

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health

Effects of exercise and diet on chronic disease

Increased oxidative stress in obesity and its impact on metabolic syndrome

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

Prostatic growth rate determined from MRI data: age-related longitudinal changes.

A note on robust variance estimation for cluster-correlated data.

Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging.

Benign prostatic hyperplasia: an overview.

P304

2562-2568

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2005-2799

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7171056

http://www.w3.org/2001/XMLSchema#string

P698

16608892

http://www.w3.org/2001/XMLSchema#string

P932

2645661

http://www.w3.org/2001/XMLSchema#string